Prescription weight loss that puts you first

Get started

Comparing Oral vs. Injectable Semaglutide

Craig Primack MD

Reviewed by Craig Primack, MD, FACP, FAAP, FOMA

Written by Hadley Mendelsohn

Published 04/24/2024

Updated 09/10/2025


Key takeaways

Semaglutide is a medication that can support weight loss. It’s available as both oral tablets and injections. The oral form offers a needle-free option but typically needs to be taken every day, while injections are usually administered weekly.

Many people know semaglutide for its injectable forms, like Ozempic® and Wegovy®, but the oral version, Rybelsus®, works similarly and can be an alternative for some people.

Let’s break down the differences between oral versus injectable semaglutide for weight loss, including effectiveness, dosing, and side effects, so you can see which option may fit your needs.

Semaglutide is the active ingredient in the injectable type 2 diabetes medication Ozempic® and the weight loss medication Wegovy®.

It’s a glucagon-like peptide-1 receptor agonist (or GLP-1 RA) that works by mimicking the GLP-1 hormone, which is naturally produced in the gut.

According to the pharmaceutical manufacturer Novo Nordisk and the FDA’s drug insert for Wegovy®, injectable semaglutide has several effects on the body, including:

  • Managing blood sugar levels. It increases insulin production and releases it into the bloodstream to help lower blood sugar (glucose) when it is high.

  • Regulating appetite. It interacts with parts of the brain to reduce appetite and signal to the body that you’re full.

  • Helping you eat less. By slowing how quickly food moves through the stomach, it can help you feel full sooner and stay full longer, leading to reduced calorie intake.

  • Lose weight and keep it off. When used along with a reduced-calorie diet and increased physical activity, Wegovy® has been shown to support long-term weight loss and weight maintenance.

The U.S. Food and Drug Administration (FDA) has approved three products containing semaglutide, all made by Novo Nordisk. While the active ingredient is the same, Rybelsus® comes as an oral tablet, and Ozempic® and Wegovy® are injectable.

Here’s what to know about taking semaglutide as a tablet versus an injection for weight loss.

Rybelsus®

Rybelsus® is FDA-approved to treat type 2 diabetes. It’s meant to be used alongside a nutrition plan and regular physical activity to manage blood sugar levels.

This drug doesn’t have FDA approval for weight loss, but some providers prescribe Rybelsus® off-label for this purpose. (Off-label use is when a medication is prescribed to treat a condition it’s not FDA-approved for — in this case, overweight or obesity.)

Ozempic®

Like Rybelsus®, Ozempic® injections are FDA-approved for people with type 2 diabetes. This medication is meant to be used with healthy eating habits and exercise to improve blood sugar levels.

Ozempic® also has FDA approval to help prevent major cardiovascular events like stroke or heart attack in folks with diabetes who also have heart disease. Ozempic® is sometimes prescribed off-label for weight loss, too.

Wegovy®

Wegovy® is a once-weekly semaglutide injection that’s FDA-approved to be used alongside healthy eating and exercise to treat obesity.

This medication may also be prescribed to people with an overweight BMI (body mass index) who have a weight-related condition, such as high blood pressure (hypertension), heart disease, or sleep apnea.

Semaglutide Tablets vs. Injections: Pros and Cons

According to Craig Primack, MD, a physician specializing in obesity medicine and the Senior Vice President of Weight Loss at Hims & Hers, “Patients taking injectable semaglutide typically lose more weight than those on oral semaglutide.”

The reason for this, Dr. Primack explains, “is because the dose of the injectable form achieves higher blood levels and, therefore, better appetite control.”

Does oral semaglutide work? Short answer: Oral semaglutide may not be as effective as injectable semaglutide for weight loss.

While both versions typically help people lose weight, injectable semaglutide may lead to more significant weight loss. But both oral and injectable semaglutide help effectively lower blood sugar levels.

Research on Oral vs. Injectable Semaglutide

Research sponsored by Novo Nordisk in patients with type 2 diabetes found that:

  • Together with diet and exercise, Ozempic® led to an average weight loss of almost 10 pounds (in those with diabetes)

  • Rybelsus® led to an average weight loss of over eight pounds

It’s important to note, though, that these trials involved lower doses of semaglutide (Ozempic®) than those sometimes used to treat obesity.

In clinical trials of Wegovy®, which included a higher dose of injectable semaglutide (2.4 mg), people lost an average of almost 15 percent of their body weight.

The bottom line: When it comes to oral semaglutide versus injectable, the latter may be more effective for weight loss.

Rybelsus® is the current oral formulation of semaglutide, but additional semaglutide tablets may be available in the future. Here’s what we know.

Novo Nordisk has been studying a high-dose form of semaglutide that can be taken by mouth specifically for weight loss.

The company previously announced that clinical trial participants lost an average of 17.4 percent of their baseline body weight after 68 weeks of using this new oral formulation. Those who took a placebo lost only 1.8 percent of their baseline body weight.

The most common side effects of both oral semaglutide and injectable semaglutide impact the gastrointestinal system. They can include:

  • Nausea

  • Vomiting

  • Constipation

  • Diarrhea

  • Upset stomach

  • Heartburn (acid reflux)

If you’re trying to decide between the oral form of semaglutide and injectable semaglutide, you may be wondering if one leads to a higher frequency of side effects or more intense adverse effects.

Research on this topic is scarce so far, but right now, there appears to be no difference between the two.

A 2024 Novo Nordisk-funded study found that there wasn’t a significant difference in the number of people reporting side effects for each form of semaglutide.

Oral semaglutide weight loss medication (that is, the diabetes medication prescribed off-label for weight loss) is taken once daily by mouth. Seems pretty simple, right?

However, there’s actually a bit of nuance to be aware of. The prescribing information for Rybelsus® also says to:

  • Take it when you first wake up, before eating or drinking anything, while you still have an empty stomach

  • Swallow each tablet whole, using only a small sip of water (four ounces or less)

  • Wait 30 minutes before having additional liquids, food, or other oral medications

When in doubt, go with your healthcare provider’s instructions and reach out to them if you’re ever unsure how to take your medication.

Injectable semaglutide is taken once weekly. It’s given as a subcutaneous injection. This means it’s injected into the layer of fatty tissue that lies just under the skin (not into a vein or muscle).

If you’re unsure about how to take semaglutide for weight loss or diabetes, don’t worry. A healthcare provider will walk you through the steps before it’s time to do it yourself.

There are a few injection sites you can use to inject subcutaneous semaglutide:

  • Abdomen

  • Thigh

  • Upper arm

It’s perfectly normal to have concerns about pain during or after an injection. If that’s you, some research suggests that subcutaneous injections in the abdomen (a few inches to either side of the belly button) are less painful than those given in the thigh.

The prescribing information for both Ozempic® and Wegovy® has additional injection instructions:

  • Do your injection on the same day each week. That said, you can do your injection any time that day.

  • It’s possible to change your injection day as long as your last injection was at least two days ago. But check with your healthcare provider first.

  • Don’t use the exact same injection site for each dose. Be sure to regularly rotate your injection site to avoid irritation or bruising.

  • Your injection can be done with or without food.

Learn more about how to inject semaglutide in our guide.

There is no one-size-fits-all answer for which form of semaglutide is best. The version a medical provider recommends can depend on its use.

Here’s what to keep in mind about oral versus injectable semaglutide:

  • Rybelsus® is currently the only brand-name version of oral semaglutide. Ozempic® and Wegovy® are the brands for the injectable form of semaglutide.

  • Wegovy® is currently the only semaglutide product FDA-approved specifically for weight management, while other semaglutide medications may be prescribed off-label for weight loss.

  • Personal preference can also play a role in figuring out the best medication. Some folks might be perfectly okay doing once-weekly injections, but the idea of self-administering an injection may not appeal to others. If you’d rather swallow pills, semaglutide tablets might be the way to go. If not, there are other oral weight loss medications.

Whichever way you’re leaning for this GLP-1 receptor agonist medication (or another weight loss drug), your first step is connecting with a healthcare professional.

Through Hers, you can connect with a licensed healthcare provider who can evaluate your health profile and needs, then let you know if you’re a good candidate for weight loss medications. If eligible, you can access a range of weight loss treatments, including oral medications and injections.

18 Sources

  1. Chowdhury SR, et al. (2024). Real-world use of oral and subcutaneous semaglutide in routine clinical practice in the UK: A single-centre, retrospective observational study. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10951141/
  2. Collins L, et al. (2024). Glucagon-like peptide-1 receptor agonists. https://www.ncbi.nlm.nih.gov/books/NBK551568/
  3. Corcoran CA, et al. (2023). Metformin. https://www.ncbi.nlm.nih.gov/books/NBK518983/
  4. Davies M, et al. (2017). Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes http://www.ncbi.nlm.nih.gov/pmc/articles/pmc5817971/
  5. Fadini GP, et al. (2024). Oral or injectable semaglutide for the management of type 2 diabetes in routine care: a multicentre observational study comparing matched cohorts. https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15554
  6. Fariba KA, et al. (2024). Topiramate. https://www.ncbi.nlm.nih.gov/books/NBK554530/
  7. Huecker MA, et al. (2023). Bupropion. https://www.ncbi.nlm.nih.gov/books/NBK470212/
  8. Meier JJ. (2021). Efficacy of semaglutide in a subcutaneous and an oral formulation. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269445/
  9. National Library of Medicine. (2024). Semaglutide injection. https://medlineplus.gov/druginfo/meds/a618008.html
  10. Novo Nordisk. (2023). Company announcement: Novo Nordisk A/S: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people adhered to treatment) in adults with obesity or overweight in the OASIS 1 trial. https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=166110
  11. Novo MedLink. (n.d.). Wegovy® mechanism of action https://www.novomedlink.com/obesity/products/treatments/wegovy/about-wegovy/how-wegovy-works.html
  12. Ozempic (semaglutide) injection, for subcutaneous use. (2022). https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637Orig1s009lbl.pdf
  13. Rybelsus (semaglutide) tablets, for oral use. (2024). https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213051s018lbl.pdf
  14. Singh DH, et al. (2023). Naltrexone. https://www.ncbi.nlm.nih.gov/books/NBK534811/
  15. Usach I, et al. (2019). Subcutaneous injection of drugs: Literature review of factors influencing pain sensation at the injection site. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822791/
  16. U.S. Food and Drug Administration (FDA). (2024). Medications containing semaglutide marketed for type 2 diabetes or weight loss. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
  17. Wegovy® (semaglutide) injection, for subcutaneous use. (2023). https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
  18. Wilding JP, et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
Editorial Standards

Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!

This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.

Related Articles

Related Conditions

Obesity Obesity
Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, such as heart disease, diabetes, and even some cancers.
Diabetes Diabetes
Diabetes is a condition that causes blood sugar levels to become higher than normal. This is due to problems with how the body makes or uses insulin, the hormone that manages blood sugar (glucose) levels.
Fatty Liver Disease Fatty Liver Disease
Fatty liver disease is when fat builds up in your liver. It can lead to liver scarring, liver damage, and liver cancer. You might not experience any symptoms of fatty liver disease until it causes health issues.
Cardiovascular Disease Cardiovascular Disease
Cardiovascular disease is a group of conditions that cause problems with your heart and blood vessels. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death worldwide. They lead to a combined 17.9 million deaths per year.
Hypertension Hypertension
Hypertension — aka high blood pressure — occurs when the heart generates too much pressure in the blood vessels. It affects half of American adults, but it often has no symptoms. Untreated hypertension can lead to stroke, heart attack, and heart disease, so it’s important to get your blood pressure checked regularly.
Insulin Resistance Insulin Resistance
Insulin is a pancreatic hormone that allows the body to lower blood sugar levels (glucose) after eating. People with insulin resistance usually produce more insulin to offset their body’s insufficient response.
Get personalized treatment

Doctor-trusted treatment plans tailored to your unique needs